Endophthalmitis (Ophthalmia) Summary

Networked: 2842 relevant articles (206 outcomes, 330 trials/studies) for this Disease

Key Drugs and Agents for Endophthalmitis

1. Anti-Bacterial Agents (Antibiotics) : 25 outcomes 35 studies in 355 results : IBA
   
2. Vancomycin : 19 outcomes 13 studies in 123 results : FDA 23 Generic
   
3. Fluconazole (Zonal) : 14 outcomes 5 studies in 48 results : FDA 41 Generic
   
4. Amphotericin B (Amphotericin) : 11 outcomes 3 studies in 77 results : FDA 12 Generic
   
5. moxifloxacin (Avelox) : 9 outcomes 9 studies in 57 results : FDA 8
   
6. voriconazole (Vfend) : 9 outcomes 5 studies in 55 results : FDA 8 Generic
   
7. Cefuroxime (Zinacef) : 8 outcomes 16 studies in 47 results : FDA 6 Generic
   
8. Ofloxacin (Levofloxacin) : 8 outcomes 10 studies in 50 results : FDA 49 Generic
   
9. Dexamethasone (Maxidex) : 7 outcomes 10 studies in 39 results : FDA 77 Generic
   
10. Povidone-Iodine (Betadine) : 7 outcomes 8 studies in 50 results : FDA 42 Generic
    

Diseases Related to Endophthalmitis

1. Cataract (Cataracts)
2. Keratitis
3. Infection
4. Wounds and Injuries (Trauma)
5. Inflammation

Key Therapies for Endophthalmitis

1. Vitrectomy : 32 outcomes 98 studies in 544 results
   
2. Intravitreal Injections : 18 outcomes 25 studies in 258 results
   
3. Antibiotic Prophylaxis : 5 outcomes 10 studies in 37 results
   
4. Intraocular Lenses (Intraocular Lens) : 5 outcomes 9 studies in 139 results
   
5. Phacoemulsification : 4 outcomes 13 studies in 89 results